Among patients undergoing coronary stenting for ischemic heart disease, bivalirudin and heparin are two anticoagulant options. Bivalirudin, a newer anticoagulant, has been touted as being as effective as generic heparin, but with nearly half the rate of bleeding. However, several studies have hinted that, compared with heparin, bivalirudin-based regimens might not protect as well against recurrent heart attacks and might increase the risk of stents clotting off. ...Sunday 17 August 2014
Research Sheds Light on Use of Bivalirudin Versus Heparin in Patients Planned for Coronary Stenting
Among patients undergoing coronary stenting for ischemic heart disease, bivalirudin and heparin are two anticoagulant options. Bivalirudin, a newer anticoagulant, has been touted as being as effective as generic heparin, but with nearly half the rate of bleeding. However, several studies have hinted that, compared with heparin, bivalirudin-based regimens might not protect as well against recurrent heart attacks and might increase the risk of stents clotting off. ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment